Eli Lilly is a safer way to capitalize on AI-driven drug discovery.

Now, it’s worth noting Stock Advisor’s total average return is 983 % — a market-crushing outperformance compared to 195% for ...

While the drop in Ultragenyx stock certainly provides a lower entry point for new investors, the more prudent choice right ...

For most drugmakers, the US is the largest single market. Prices there are often close to three times higher than in other ...

O4, Jared Holz of Mizuho joined ‘Power Lunch’ on CNBC to talk about how to play biotech moving into 2026. Holz noted that ...

Discover the top 3 undervalued Pharmaceuticals stocks for Wednesday, December 31 based on AAII’s Stock Grades.

As of Wednesday, December 31, Vanda Pharmaceuticals Inc.’s VNDA share price has surged by 34.23%, which has investors ...

The VanEck Pharmaceutical ETF provides diversified exposure to the world's largest pharmaceutical companies, focusing on 'big pharma' through a cap-weighted index. PPH tracks the MVIS US Listed ...

William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage ...

Abivax SA soared about 1,300% after successful trial results for a bowel disease drug, Argenx SE was added to the elite Euro ...